Blake Waechter

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)”.

Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)

Seminars in Oncology(2023)10.1053/j.seminoncol.2023.01.001

N/A

0.432DataRank · unranked

7 citations

David M. Zahrieh, Jun He, Blake Waechter, Julianne L. Holleran, Lionel D. Lewis +9 more

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

The Oncologist(2025)10.1093/oncolo/oyaf069

N/A

0.232DataRank · unranked

3 citations

Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0DataRank · unranked

35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more